Skip to main content
  • Home
  • Cerba HealthCare
Institutional profile

Cerba HealthCare

Cerba HealthCare is a major European laboratory medicine group with a strong presence in routine clinical pathology, specialty diagnostics, anatomic pathology, and clinical trial laboratory services. The company reports 1,200 clinical pathologists and 1,360 laboratories across France, Luxembourg, Belgium, Italy, and Africa, supported by broader specialty entities including Cerba Research and Cerba Path.

  • Highest 2026 tier: Tier II
  • Pathology & Laboratory Networks
  • 1 ranking category

Overview

Cerba HealthCare is a major European laboratory medicine group with a strong presence in routine clinical pathology, specialty diagnostics, anatomic pathology, and clinical trial laboratory services. The company reports 1,200 clinical pathologists and 1,360 laboratories across France, Luxembourg, Belgium, Italy, and Africa, supported by broader specialty entities including Cerba Research and Cerba Path.

Cerba’s strength lies in its combination of local laboratory proximity and specialist capabilities. Routine laboratory networks depend on collection access and turnaround time, while specialty laboratories require expertise, quality systems, and clinical interpretation. Cerba operates across both segments.

Cerba HealthCare is included in 1 2026 ranking category. Its highest classification is Tier II. Ranking recognition is category-specific editorial evidence rather than a substitute for independent diligence.

Firm facts

Public identityCerba HealthCare
Founded1967
Institution typePathology & Laboratory Networks institution
HeadquartersIssy-les-Moulineaux, France
Primary focusPathology & Laboratory Networks
Highest 2026 ranking tierTier II

Principal activities

Cerba’s strength lies in its combination of local laboratory proximity and specialist capabilities. Routine laboratory networks depend on collection access and turnaround time, while specialty laboratories require expertise, quality systems, and clinical interpretation. Cerba operates across both segments.

Core capability

Pathology & Laboratory Networks

Client relevance

Category-specific capability, institutional credibility and the ability to support demanding professional, commercial or patient needs.

Execution and verification

Current service scope, leadership, geographic coverage, legal entities and regulated activities should be confirmed directly.

Sector and mandate coverage

Primary category

Pathology & Laboratory Networks

Institutional context

Coverage reflects the institution’s role in the ranking categories listed below. Precise services, products, jurisdictions, clinical scope and client eligibility should be verified for each use case.

Market position

The company is also relevant to precision medicine and biopharmaceutical development through Cerba Research, which operates across five continents and supports complex clinical trials with specialty laboratory testing. Its geographic reach, clinical pathology platform, and specialty testing capabilities support its position among established laboratory networks.

Cerba HealthCare is assessed through public institutional information and Ranking News editorial research. Its strongest 2026 result is Tier II.

Competitive context

The relevant peer set varies by category, geography, client segment and mandate. Cerba HealthCare should be compared on current category-specific capability, senior involvement, evidence of comparable work, operating resilience and any applicable regulatory or clinical permissions.

Comparable institutions are shown for navigation and market context. Inclusion does not imply identical scale, ownership, geographic coverage, service model or regulatory status.

Leadership and governance

Leadership, ownership, governance and senior-team responsibilities may change. Current information should be verified through authoritative institutional sources.

Corporate and public information

The public-facing organization is identified here as Cerba HealthCare. Contracting entities, regulated affiliates, clinical operations, offices and legal permissions may differ by service and jurisdiction.

Corporate and disclosure information
OrganizationCerba HealthCare
HeadquartersIssy-les-Moulineaux, France
Verification noteConfirm legal entity, licenses, offices and engagement terms directly before appointment or use.

Rankings and recognition

2026

Tier II

Ranking inclusion and tier classification are editorial determinations. They should be read as category-specific assessments rather than universal league-table positions. The existence or maintenance of this Wiki profile does not influence ranking eligibility, tier or position.

Related Economy analysis

Selected reporting and market analysis from The Economy provides context for the institution’s operating environment:

Sources and data transparency

Official institutional information, where available, is used for current public identity and capabilities. Ranking pages document 2026 category and tier status. Economy articles provide market context rather than institution-specific endorsement.

  1. Healthcare Ranking — Top 30 Pathology & Laboratory Networks 2026 — 2026 inclusion and tier classification.
  2. The Economy — Healthcare Rankings and the New Economics of Expertise — market context.
  3. The Economy — Healthcare Market Structure Is Opening a New Lane for Specialist Providers — market context.
  4. The Economy — Healthcare Rankings and the New Geography of Distributed Care — market context.

First published: 29 August 2026

Last substantively reviewed: 29 August 2026

Profile scope: Pathology & Laboratory Networks

This profile has been compiled from publicly available institutional and editorial sources. The profiled organization does not determine its inclusion, editorial characterization or ranking status. Corrections supported by authoritative documentation may be submitted to The Economy Wiki.